We are live on ! Find out more
FWM

Frontier Wealth Management Portfolio holdings

AUM $1.38B Turnover 16.82%
1-Year Est. Return 6.3%
This Fund
S&P 500
This Quarter Est. Return
-12.46%
1 Year Est. Return
+6.3%
3 Year Est. Return
+42.77%
5 Year Est. Return
+78.1%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
-$6.65B
Cap. Flow
-$5.8B
Cap. Flow %
-421.12%
Top 10 Hldgs %
32.64%
Holding
434
New
30
Increased
120
Reduced
163
Closed
43
Avg Time Held
3.7 years
Top 10 Avg Time Held
2.2 years
Top 20 Avg Time Held
2.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 44.95%
2 Financials 10.62%
3 Technology 9.58%
4 Energy 7.1%
5 Healthcare 7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HGEN
376
DELISTED
Humanigen
HGEN
$108K 0.01%
61,000
– –
2022 Q1
1 quarter
PR icon
377
Permian Resources
PR
$18B
$93K 0.01%
15,570
– –
2018 Q4
14 quarters
NUV icon
378
Nuveen Municipal Value Fund
NUV
$1.71B
$89K 0.01%
+10,000
New +$90.6K
2022 Q2
0 quarters
HOOD icon
379
Robinhood
HOOD
$62.5B
$82K 0.01%
10,000
– –
2022 Q1
1 quarter
ADPT icon
380
Adaptive Biotechnologies
ADPT
$4.63B
$81K 0.01%
10,000
– –
2021 Q2
4 quarters
GUT icon
381
Gabelli Utility Trust
GUT
$456M
$75K 0.01%
11,388
– –
2020 Q1
9 quarters
ACON icon
382
Aclarion
ACON
$3.89M
– –
0
– –
2022 Q2
0 quarters
NKTR icon
383
Nektar Therapeutics
NKTR
$1.2B
$46K ﹤0.01%
800
– –
2021 Q4
2 quarters
JNCE
384
DELISTED
Jounce Therapeutics
JNCE
$40K ﹤0.01%
13,099
– –
2018 Q1
17 quarters
IRD icon
385
Opus Genetics
IRD
$383M
$35K ﹤0.01%
18,000
-3,000
-14% -$6.82K
2021 Q3
3 quarters
SERA icon
386
Sera Prognostics
SERA
$78.3M
$29K ﹤0.01%
17,841
+5,941
+50% +$11.4K
2022 Q1
1 quarter
AUUDW icon
387
DELISTED
Auddia Inc Warrants
AUUDW
$21K ﹤0.01%
53,500
– –
2021 Q3
3 quarters
SRNE
388
DELISTED
Sorrento Therapeutics
SRNE
$21K ﹤0.01%
10,500
-10,000
-49% -$17.3K
2022 Q1
1 quarter
KPLT icon
389
Katapult Holdings
KPLT
$839M
$20K ﹤0.01%
740
– –
2021 Q1
5 quarters
UNCY icon
390
Unicycive Therapeutics
UNCY
$103M
$16K ﹤0.01%
1,880
– –
2021 Q3
3 quarters
NMTR
391
DELISTED
9 Meters Biopharma
NMTR
$8K ﹤0.01%
1,500
– –
2021 Q1
5 quarters
ABEV icon
392
Ambev
ABEV
$41.9B
– –
-10,000
Closed -$32K –
APH icon
393
Amphenol
APH
$190B
– –
-12,280
Closed -$220K –
BNTX icon
394
BioNTech
BNTX
$20.8B
– –
-2,570
Closed -$435K –
BWA icon
395
BorgWarner
BWA
$10.1B
– –
-7,613
Closed -$248K –
CF icon
396
CF Industries
CF
$16.9B
– –
-2,755
Closed -$303K –
CGTX icon
397
Cognition Therapeutics
CGTX
$58M
– –
-50,000
Closed -$152K –
CHD icon
398
Church & Dwight
CHD
$26.5B
– –
-2,150
Closed -$223K –
CHRW icon
399
C.H. Robinson
CHRW
$16B
– –
-6,180
Closed -$627K –
CMG icon
400
Chipotle Mexican Grill
CMG
$46.5B
– –
-10,350
Closed -$317K –

Similar funds

Frontier Wealth Management's Q2 2022 Portfolio in Review

As of Q2 2022, Frontier Wealth Management held 434 positions worth $1.38B, down 83% from $8.03B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Frontier Wealth Management withdrew a net $5.8B in Q2 2022, closing 43 positions and reducing 163 holdings. Its most notable exit was Cerner, an estimated $757K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, up from 8.1% a quarter earlier, followed by Financials and Technology.

Against the trend, Frontier Wealth Management opened a new position in iShares 7-10 Year Treasury Bond ETF worth $67.6M.

  • Frontier Wealth Management's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 661,050 shares worth $67.6M.
  • Frontier Wealth Management added most to Schwab US Large- Cap ETF in Q2 2022, an estimated $34.5M increase.
  • Frontier Wealth Management's biggest Q2 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $5.87B.
  • Frontier Wealth Management fully exited Cerner in Q2 2022, selling an estimated $757K.
  • Frontier Wealth Management's ten largest holdings make up 33% of its $1.38B portfolio in Q2 2022.
  • Frontier Wealth Management opened 30 new positions and closed 43 in Q2 2022.
  • Frontier Wealth Management's portfolio value fell 83% quarter-over-quarter to $1.38B.

Based on Frontier Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.